tiprankstipranks
Viridian Therapeutics (VRDN)
NASDAQ:VRDN

Compare Viridian Therapeutics (VRDN) vs. Competitors

1,505 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Viridian Therapeutics
$14.80
$1.51B
-5.48
14.21%
13 Buy
1 Hold
0 Sell
Strong Buy
Dianthus Therapeutics
$90.00
$4.76B
-9.59
407.27%
16 Buy
0 Hold
0 Sell
Strong Buy
Pharvaris
$27.88
$1.79B
-7.95
127.26%
7 Buy
1 Hold
0 Sell
Strong Buy
Edgewise Therapeutics
$33.84
$3.63B
-12.72
168.94%
7 Buy
0 Hold
0 Sell
Strong Buy
Janux Therapeutics Inc
$14.90
$906.39M
-7.53
-47.36%
14 Buy
1 Hold
0 Sell
Strong Buy
Biohaven Ltd.
$10.12
$1.52B
-1.64
-43.60%
8 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VRDN
Viridian Therapeutics
15.19
2.39
18.67%
DNTH
Dianthus Therapeutics
94.91
75.70
394.07%
PHVS
Pharvaris
28.68
14.74
105.74%
EWTX
Edgewise Therapeutics
33.16
20.14
154.69%
JANX
Janux Therapeutics Inc
15.24
-13.82
-47.56%
BHVN
Biohaven Ltd.
10.44
-8.12
-43.75%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts